Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-2-23
pubmed:abstractText
A series of 1-[3-(4-substituted phenylthio) propyl]-4-(substituted phenyl) piperazines has been synthesized and evaluated for hypotensive activity. The QSAR studies indicate that resonance and hydrophobic parameters of the aryl substituents are important for hypotensive activity. The similar role of resonance parameter in describing the variance of 5-HT(2A) receptor binding affinities of these compounds suggests a possible role of 5-HT(2A) receptors in mediating the hypotensive action of title compounds.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0960-894X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1708-12
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:17234413-Animals, pubmed-meshheading:17234413-Antihypertensive Agents, pubmed-meshheading:17234413-Blood Pressure, pubmed-meshheading:17234413-Cats, pubmed-meshheading:17234413-Chemistry, Physical, pubmed-meshheading:17234413-Female, pubmed-meshheading:17234413-Indicators and Reagents, pubmed-meshheading:17234413-Magnetic Resonance Spectroscopy, pubmed-meshheading:17234413-Male, pubmed-meshheading:17234413-Mass Spectrometry, pubmed-meshheading:17234413-Mice, pubmed-meshheading:17234413-NIH 3T3 Cells, pubmed-meshheading:17234413-Physicochemical Phenomena, pubmed-meshheading:17234413-Piperazines, pubmed-meshheading:17234413-Pyrroles, pubmed-meshheading:17234413-Quantitative Structure-Activity Relationship, pubmed-meshheading:17234413-Receptor, Serotonin, 5-HT2A, pubmed-meshheading:17234413-Spectrophotometry, Infrared
pubmed:year
2007
pubmed:articleTitle
Synthesis and QSAR studies on hypotensive 1-[3-(4-substituted phenylthio) propyl]-4-(substituted phenyl) piperazines.
pubmed:affiliation
Medicinal and Process Chemistry Division, Central Drug Research Institute, Lucknow 226001, India. anilsak@gmail.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't